Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0F7DQ
|
|||
Former ID |
DNC008275
|
|||
Drug Name |
Triphenylacetic acid methyl ester
|
|||
Synonyms |
methyl triphenylacetate; methyl 2,2,2-triphenylacetate; 5467-21-0; triphenylacetic acid methyl ester; CHEMBL270495; 2-TRIPHENYL METHYL ACETIC ACID; NSC28082; methyl triphenyl-acetate; AC1Q5YRI; SCHEMBL7258414; AC1L5M42; CTK5A2196; DTXSID30282812; ZPGOQUZHRVSLML-UHFFFAOYSA-N; ZINC4696706; BDBM50371380; NSC-28082; Benzeneacetic acid, a,a-diphenyl-, methyl ester; benzeneacetic acid, .alpha.,.alpha.-diphenyl-, methyl ester
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C21H18O2
|
|||
Canonical SMILES |
COC(=O)C(C1=CC=CC=C1)(C2=CC=CC=C2)C3=CC=CC=C3
|
|||
InChI |
1S/C21H18O2/c1-23-20(22)21(17-11-5-2-6-12-17,18-13-7-3-8-14-18)19-15-9-4-10-16-19/h2-16H,1H3
|
|||
InChIKey |
ZPGOQUZHRVSLML-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 5467-21-0
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Calcium-activated potassium channel (KCN) | Target Info | Inhibitor | [1] |
References | Top | |||
---|---|---|---|---|
REF 1 | Novel inhibitors of the Gardos channel for the treatment of sickle cell disease. J Med Chem. 2008 Feb 28;51(4):976-82. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.